Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Boehringer Ingelheim
Baxter
Express Scripts
McKesson

Last Updated: June 29, 2022

Dopamine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for dopamine hydrochloride and what is the scope of freedom to operate?

Dopamine hydrochloride is the generic ingredient in six branded drugs marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for dopamine hydrochloride. Eight suppliers are listed for this compound.

Summary for dopamine hydrochloride
Recent Clinical Trials for dopamine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lund UniversityPhase 3
Region SkanePhase 3
Intra-Cellular Therapies, Inc.Phase 2

See all dopamine hydrochloride clinical trials

Pharmacology for dopamine hydrochloride
Drug ClassCatecholamine
Medical Subject Heading (MeSH) Categories for dopamine hydrochloride

US Patents and Regulatory Information for dopamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Igi Labs Inc DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070087-001 Oct 23, 1985 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva Parenteral DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 073000-001 Oct 23, 1991 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Smith And Nephew DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070046-001 Aug 29, 1985 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Igi Labs Inc DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070089-001 Oct 23, 1985 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira INTROPIN dopamine hydrochloride INJECTABLE;INJECTION 017395-003 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Warner Chilcott DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070559-001 Sep 20, 1985 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Johnson and Johnson
AstraZeneca
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.